Please login to the form below

Not currently logged in
Email:
Password:

Lucid expands with launch of new strategic consultancy

Its new company will be led by Duncan Ferguson

Lucid Strategic Consultancy Duncan Ferguson

The Lucid Group has expanded its operations with the launch of a new consultancy and appointed Duncan Ferguson (pictured above) to lead the venture.

Lucid Strategic Consultancy will provide a range of strategic consultancy services, covering areas such as early pipeline development, brand launch and mature product planning.

Ferguson, its new managing director, joins Lucid from LEO Pharma, where he spent seven years, most recently serving as its senior vice president of global commercial strategy.

Prior to that he worked at Abbott Laboratories, holding senior UK and international marketing roles.

Ferguson said: ““I’m passionate about inspiring others to make a sustainable impact with their strategy development and implementation. I have worked with Lucid for several years, and see a perfect fit for myself within this exciting company.

“I have experienced the true challenges faced by leaders and brand teams, so I know where the gaps in pharma are and what it takes to make a difference.”

Lucid said its new consultancy would offer “a new way of thinking, called momentum strategy” to generate commercial value that was developed following intensive research of some of the world’s most successful consumer brands.

Article by
Dominic Tyer

9th March 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics